Advanced search
Publication Cover
Autoimmunity Volume 38, 2005 - Issue 2
Submit an article Journal homepage
184
Views
80
CrossRef citations to date
0
Altmetric
Original Article

Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression

Gunilla Nordin Fredrikson Department of Medicine, Malmö University Hospital, Lund University, Malmö, Sweden; Department of Biomedical Laboratory Science, Malmö University, Malmö, SwedenCorrespondence[email protected]
,
Linda Andersson Department of Medicine, Malmö University Hospital, Lund University, Malmö, Sweden
,
Ingrid Söderberg Department of Medicine, Malmö University Hospital, Lund University, Malmö, Sweden
,
Paul Dimayuga Atherosclerosis Research Center, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA
,
Kuang-Yuh Chyu Atherosclerosis Research Center, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA
,
Prediman K. Shah Atherosclerosis Research Center, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA
&
Jan Nilsson Department of Medicine, Malmö University Hospital, Lund University, Malmö, Sweden
 show all
Pages 171-179 | Received 18 Aug 2004, Accepted 10 Jan 2005, Published online: 07 Jul 2009

Citations (80)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Ling-Zhi Hong, Qi Xue & Hong Shao. (2021) Inflammatory Markers Related to Innate and Adaptive Immunity in Atherosclerosis: Implications for Disease Prediction and Prospective Therapeutics. Journal of Inflammation Research 14, pages 379-392.
Read now
Dania O. Govea-Alonso, Josué Beltrán-López, Jorge A. Salazar-González, Juan Vargas-Morales & Sergio Rosales-Mendoza. (2017) Progress and future opportunities in the development of vaccines against atherosclerosis. Expert Review of Vaccines 16:4, pages 337-350.
Read now
Hanna A. Jensen & Jawahar L. Mehta. (2016) Endothelial cell dysfunction as a novel therapeutic target in atherosclerosis. Expert Review of Cardiovascular Therapy 14:9, pages 1021-1033.
Read now
Takayuki Kimura, Kevin Tse, Alessandro Sette & Klaus Ley. (2015) Vaccination to modulate atherosclerosis. Autoimmunity 48:3, pages 152-160.
Read now
Tiago Morais, Sara Andrade, Sofia S Pereira & Mariana P Monteiro. (2014) Vaccines for metabolic diseases: current perspectives. Vaccine: Development and Therapy 4, pages 55-72.
Read now
Jan Nilsson, Maria Wigren & Prediman K Shah. (2013) Vaccines against atherosclerosis. Expert Review of Vaccines 12:3, pages 311-321.
Read now
Gerald H Tomkin. (2010) Atherosclerosis, diabetes and lipoproteins. Expert Review of Cardiovascular Therapy 8:7, pages 1015-1029.
Read now
Gunilla Nordin Fredrikson, Marie W. Lindholm, Irena Ljungcrantz, Ingrid Söderberg, Prediman K. Shah & Jan Nilsson. (2007) Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice. Autoimmunity 40:2, pages 122-130.
Read now
Patrick Mathieu, Philippe Pibarot & Jean-Pierre Després. (2006) Metabolic Syndrome: The Danger Signal in Atherosclerosis. Vascular Health and Risk Management 2:3, pages 285-302.
Read now
Jan Nilsson, Gunilla Nordin Fredrikson, Kuang-Yuh Chyu, Prediman Shah & Harry Björkbacka. (2006) Oxidized lipoprotein autoimmunity: an emerging drug target in cardiovascular disease. Future Lipidology 1:3, pages 321-330.
Read now

Articles from other publishers (70)

Dalgisio Lecis, Gianluca Massaro, Daniela Benedetto, Marco Di Luozzo, Giulio Russo, Alessandro Mauriello, Massimo Federici & Giuseppe Massimo Sangiorgi. (2023) Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future. International Journal of Molecular Sciences 24:13, pages 10979.
Crossref
Miguel A. Moreno-Gonzalez, Oscar A. Ortega-Rivera & Nicole F. Steinmetz. (2023) Two decades of vaccine development against atherosclerosis. Nano Today 50, pages 101822.
Crossref
Zihan MaChenfeng MaoXiao ChenShiyu YangZhihua QiuBaoqi YuYiting Jia, Chao WuYiyi WangYuhui WangRui GuFang YuYanhui YinXian WangQingbo Xu, Chuanju LiuYuhua LiaoJingang ZhengYi FuWei Kong. (2023) Peptide Vaccine Against ADAMTS-7 Ameliorates Atherosclerosis and Postinjury Neointima Hyperplasia. Circulation 147:9, pages 728-742.
Crossref
Yongzheng Lu, Xiaolin Cui, Li Zhang, Xu Wang, Yanyan Xu, Zhen Qin, Gangqiong Liu, Qiguang Wang, Kang Tian, Khoon S Lim, Chris J Charles, Jinying Zhang & Junnan Tang. (2022) The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy. Aging and disease 13:2, pages 491.
Crossref
Jorge H Tabares-Guevara, Janny A Villa-Pulgarin & Juan C Hernandez. (2021) Atherosclerosis: immunopathogenesis and strategies for immunotherapy. Immunotherapy 13:14, pages 1231-1244.
Crossref
Jan Nilsson & Prediman K. Shah. (2021) Promoting athero-protective immunity by vaccination with low density lipoprotein-derived antigens. Atherosclerosis 335, pages 89-97.
Crossref
Florentina Porsch, Ziad Mallat & Christoph J Binder. (2021) Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies. Cardiovascular Research.
Crossref
Eunhye Ji & Sahmin Lee. (2021) Antibody-Based Therapeutics for Atherosclerosis and Cardiovascular Diseases. International Journal of Molecular Sciences 22:11, pages 5770.
Crossref
Justine Deroissart, Florentina Porsch, Thomas Koller & Christoph J. Binder. 2022. Prevention and Treatment of Atherosclerosis. Prevention and Treatment of Atherosclerosis 359 404 .
Felix Sebastian Nettersheim, Lauren De Vore & Holger Winkels. (2020) Vaccination in Atherosclerosis. Cells 9:12, pages 2560.
Crossref
Payel Roy, Amal J. Ali, Kouji Kobiyama, Yanal Ghosheh & Klaus Ley. (2020) Opportunities for an atherosclerosis vaccine: From mice to humans. Vaccine 38:28, pages 4495-4506.
Crossref
Jan NilssonGöran K. Hansson. (2020) Vaccination Strategies and Immune Modulation of Atherosclerosis. Circulation Research 126:9, pages 1281-1296.
Crossref
Hamideh Amirfakhryan. (2020) Vaccination against atherosclerosis: An overview. Hellenic Journal of Cardiology 61:2, pages 78-91.
Crossref
Kouji Kobiyama, Ryosuke Saigusa & Klaus Ley. (2019) Vaccination against atherosclerosis. Current Opinion in Immunology 59, pages 15-24.
Crossref
Sara Rattik, Polyxeni T. Mantani, Ingrid Yao Mattisson, Irena Ljungcrantz, Lena Sundius, Harry Björkbacka, Manuela Terrinoni, Michael Lebens, Jan Holmgren, Jan Nilsson, Maria Wigren & Gunilla Nordin Fredrikson. (2018) B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice. Vascular Pharmacology 111, pages 54-61.
Crossref
Dimitry A. Chistiakov, Alexandra A. Melnichenko, Andrey V. Grechko, Veronika A. Myasoedova & Alexander N. Orekhov. (2018) Potential of anti-inflammatory agents for treatment of atherosclerosis. Experimental and Molecular Pathology 104:2, pages 114-124.
Crossref
Ahmed Ludvigsen Al-Mashhadi, Christian Bo Poulsen, Karin von Wachenfeldt, Anna-Karin Robertson, Jacob Fog Bentzon, Lars Bo Nielsen, Jesper Thygesen, Lars Poulsen Tolbod, Jens Rolighed Larsen, Søren Kragh Moestrup, Björn Frendéus, Brynjulf Mortensen, Ludovic Drouet, Rozh H. Al-Mashhadi & Erling Falk. (2018) Diet-Induced Abdominal Obesity, Metabolic Changes, and Atherosclerosis in Hypercholesterolemic Minipigs. Journal of Diabetes Research 2018, pages 1-12.
Crossref
Su-Kang Kong, Moon Kyung Choe, Hyung-Ji Kim, Young-Sik Kim, Bert Binas & Hyo Joon Kim. (2017) An ApoB100-mimetic vaccine prevents obesity and liver steatosis in ApoE-/- mice. Pharmacological Reports 69:6, pages 1140-1144.
Crossref
Dania O. Govea-Alonso, Marlene A. Tello-Olea, Josué Beltrán-López, Elizabeth Monreal-Escalante, Jorge A. Salazar-Gonzalez, Bernardo Bañuelos-Hernández & Sergio Rosales-Mendoza. (2017) Assessment of Carrot Callus as Biofactories of an Atherosclerosis Oral Vaccine Prototype. Molecular Biotechnology 59:11-12, pages 482-489.
Crossref
Rosebella A. Iseme, Mark McEvoy, Brian Kelly, Linda Agnew, Frederick R. Walker, Tonelle Handley, Christopher Oldmeadow, John Attia & Michael Boyle. (2017) A role for autoantibodies in atherogenesis. Cardiovascular Research 113:10, pages 1102-1112.
Crossref
Kuang-Yuh Chyu, Paul C. Dimayuga & Prediman K. Shah. (2017) Vaccine against arteriosclerosis: an update. Therapeutic Advances in Vaccines 5:2, pages 39-47.
Crossref
Giuseppe AsciuttoMaria WigrenGunilla Nordin FredriksonIngrid Yao MattissonCaitriona GrönbergRagnar AlmHarry BjörkbackaNuno V. DiasAndreas EdsfeldtIsabel GonçalvesJan Nilsson. (2016) Apolipoprotein B-100 Antibody Interaction With Atherosclerotic Plaque Inflammation and Repair Processes. Stroke 47:4, pages 1140-1143.
Crossref
Derrick T. Antoniak, Michael J. Duryee, Ted R. Mikuls, Geoffrey M. Thiele & Daniel R. Anderson. (2015) Aldehyde-modified proteins as mediators of early inflammation in atherosclerotic disease. Free Radical Biology and Medicine 89, pages 409-418.
Crossref
J. Nilsson, A. Lichtman & A. Tedgui. (2015) Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges. Journal of Internal Medicine 278:5, pages 507-519.
Crossref
Victor Garc?a-Gonz?lez, Blanca Delgado-Coello, Armando P?rez-Torres & Jaime Mas-Oliva. (2015) Reality of a Vaccine in the Prevention and Treatment of Atherosclerosis. Archives of Medical Research 46:5, pages 427-437.
Crossref
Björn Fagerberg, Ulrica Prahl Gullberg, Ragnar Alm, Jan Nilsson & Gunilla Nordin Fredrikson. (2015) Circulating Autoantibodies against the Apolipoprotein B-100 Peptides p45 and p210 in Relation to the Occurrence of Carotid Plaques in 64-Year-Old Women. PLOS ONE 10:3, pages e0120744.
Crossref
Jorge Alberto Salazar-Gonzalez, Sergio Rosales-Mendoza, Andrea Romero-Maldonado, Elizabeth Monreal-Escalante, Edith Elena Uresti-Rivera & Bernardo Bañuelos-Hernández. (2014) Production of a Plant-Derived Immunogenic Protein Targeting ApoB100 and CETP: Toward a Plant-Based Atherosclerosis Vaccine. Molecular Biotechnology 56:12, pages 1133-1142.
Crossref
Daniel Engelbertsen, Sara Rattik, Anki Knutsson, Harry Björkbacka, Eva Bengtsson & Jan Nilsson. (2014) Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE−/− mice. Cardiovascular Research 103:2, pages 304-312.
Crossref
Arnon Blum. (2014) HMG-CoA reductase inhibitors (statins), inflammation, and endothelial progenitor cells-New mechanistic insights of atherosclerosis. BioFactors 40:3, pages 295-302.
Crossref
Kuang-Yuh Chyu & Prediman K. Shah. (2013) Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases. Therapeutic Advances in Vaccines 2:2, pages 56-66.
Crossref
Hironori Nakagami, Hiroshi Koriyama & Ryuichi Morishita. (2014) Therapeutic Vaccines for Hypertension and Dyslipidemia. International Heart Journal 55:2, pages 96-100.
Crossref
K. A. Krychtiuk, S. P. Kastl, W. S. Speidl & J. Wojta. (2013) Inflammation and coagulation in atherosclerosis. Hämostaseologie 33:4, pages 269-282.
Crossref
Paul N. Hopkins. (2013) Molecular Biology of Atherosclerosis. Physiological Reviews 93:3, pages 1317-1542.
Crossref
Chrysoulla Pierides, Alexandra Bermudez-Fajardo, Gunilla Nordin Fredrikson, Jan Nilsson & Ernesto Oviedo-Orta. (2013) Immune responses elicited by apoB-100-derived peptides in mice. Immunologic Research 56:1, pages 96-108.
Crossref
Lakshmi A. Mundkur, Meenakshi Varma, Hemapriya Shivanandan, Dhanush Krishna, Kiran Kumar, Xinjie Lu & Vijay. V. Kakkar. (2013) Activation of inflammatory cells and cytokines by peptide epitopes in vitro: a simple in-vitro screening assay for prioritizing them for in-vivo studies. Inflammation Research 62:5, pages 471-481.
Crossref
Jorge Alberto Salazar-González & Sergio Rosales-Mendoza. (2013) A perspective for atherosclerosis vaccination: Is there a place for plant-based vaccines?. Vaccine 31:10, pages 1364-1369.
Crossref
Renee Jaramillo, Richard D. Cohn, Patrick W. Crockett, Kymberly M. Gowdy, Darryl C. Zeldin & Michael B. Fessler. (2013) Relation between objective measures of atopy and myocardial infarction in the United States. Journal of Allergy and Clinical Immunology 131:2, pages 405-411.e11.
Crossref
Jan Nilsson, Harry Björkbacka & Gunilla Nordin Fredrikson. (2012) Apolipoprotein B100 autoimmunity and atherosclerosis – disease mechanisms and therapeutic potential. Current Opinion in Lipidology 23:5, pages 422-428.
Crossref
Olivier HerbinHafid Ait-OufellaWang YuGunilla Nordin FredriksonBenjamin AubierNicolas PerezVéronique BarateauJan NilssonAlain TedguiZiad Mallat. (2012) Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology 32:3, pages 605-612.
Crossref
Kuang-Yuh Chyu, Xiaoning Zhao, Paul C. Dimayuga, Jianchang Zhou, Xiaojun Li, Juliana Yano, Wai Man Lio, Lai Fan Chan, Jonathan Kirzner, Portia Trinidad, Bojan Cercek & Prediman K. Shah. (2012) CD8+ T Cells Mediate the Athero-Protective Effect of Immunization with an ApoB-100 Peptide. PLoS ONE 7:2, pages e30780.
Crossref
Cecilia Grundtman. 2012. Inflammation and Atherosclerosis. Inflammation and Atherosclerosis 133 169 .
Cecilia Grundtman. 2012. Inflammation and Atherosclerosis. Inflammation and Atherosclerosis 529 553 .
Daniel F.J. KetelhuthFrancisco J.O. RiosYajuan WangHuiqing LiuMaria E. JohanssonGunilla N. FredriksonUlf HedinMagnus GidlundJan NilssonGöran K. HanssonZhong-qun Yan. (2011) Identification of a Danger-Associated Peptide From Apolipoprotein B100 (ApoBDS-1) That Triggers Innate Proatherogenic Responses. Circulation 124:22, pages 2433-2443.
Crossref
M. Wigren, D. Kolbus, P. Dunér, I. Ljungcrantz, I. Söderberg, H. Björkbacka, G. N. Fredrikson & J. Nilsson. (2011) Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine. Journal of Internal Medicine 269:5, pages 546-556.
Crossref
Maria M. Stollenwerk, Olof Svensson, Alexandru Schiopu, Bo Jansson, Thomas Arnebrant & Gunilla Nordin Fredrikson. (2011) Adsorption of low-density lipoprotein, its oxidation, and subsequent binding of specific recombinant antibodies: An in situ ellipsometric study. Biochimica et Biophysica Acta (BBA) - General Subjects 1810:2, pages 211-217.
Crossref
Rongfa Chen, Hua Shao, Shiqing Lin, Jin-Jun Zhang & Kang-Qing Xu. (2012) Treatment with Astragalus membranaceus Produces Antioxidative Effects and Attenuates Intestinal Mucosa Injury Induced by Intestinal Ischemia-Reperfusion in Rats . The American Journal of Chinese Medicine 39:05, pages 879-887.
Crossref
Pontus Dunér, Fong To, Katarina Berg, Ragnar Alm, Harry Björkbacka, Daniel Engelbertsen, Gunilla Nordin Fredrikson, Jan Nilsson & Eva Bengtsson. (2010) Immune responses against aldehyde-modified laminin accelerate atherosclerosis in Apoe−/− mice. Atherosclerosis 212:2, pages 457-465.
Crossref
Tanja X. Pedersen, Christoph J. Binder, Gunilla N. Fredrikson, Jan Nilsson, Susanne Bro & Lars B. Nielsen. (2010) The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE−/− mice. Nephrology Dialysis Transplantation 25:8, pages 2486-2491.
Crossref
G.-P. Shi. (2010) Immunomodulation of Vascular Diseases: Atherosclerosis and Autoimmunity. European Journal of Vascular and Endovascular Surgery 39:4, pages 485-494.
Crossref
Ming Zhao, Maria Wigren, Pontus Dunér, Daniel Kolbus, Katarina E. Olofsson, Harry Björkbacka, Jan Nilsson & Gunilla Nordin Fredrikson. (2010) FcγRIIB Inhibits the Development of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. The Journal of Immunology 184:5, pages 2253-2260.
Crossref
Kim L.L. Habets, Gijs H.M. van Puijvelde, Leonie M. van Duivenvoorde, Eva J.A. van Wanrooij, Paula de Vos, Jan-Willem Cohen Tervaert, Theo J.C. van Berkel, Rene E.M. Toes & Johan Kuiper. (2010) Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice. Cardiovascular Research 85:3, pages 622-630.
Crossref
Michael Jan, Shu Meng, Natalie C. Chen, Jietang Mai, Hong Wang & Xiao-Feng Yang. (2010) Inflammatory and Autoimmune Reactions in Atherosclerosis and Vaccine Design Informatics. Journal of Biomedicine and Biotechnology 2010, pages 1-16.
Crossref
Shahzada Amir & Christoph J. Binder. (2010) Experimental immunotherapeutic approaches for atherosclerosis. Clinical Immunology 134:1, pages 66-79.
Crossref
Peter Libby, Paul M. Ridker & Göran K. Hansson. (2009) Inflammation in Atherosclerosis. Journal of the American College of Cardiology 54:23, pages 2129-2138.
Crossref
J. Nilsson, G. N. Fredrikson, H. Björkbacka, K.-Y. Chyu & P. K. Shah. (2009) Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease. Journal of Internal Medicine 266:3, pages 221-231.
Crossref
Isabel Gonçalves, Mihaela Nitulescu, Mikko P.S. Ares, Gunilla Nordin Fredrikson, Bo Jansson, Zhan-Chun Li & Jan Nilsson. (2009) Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions. Atherosclerosis 205:1, pages 96-100.
Crossref
G. N. Fredrikson, D. V. Anand, D. Hopkins, R. Corder, R. Alm, E. Bengtsson, P. K. Shah, A. Lahiri & J. Nilsson. (2009) Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes. Diabetologia 52:7, pages 1426-1433.
Crossref
Maria WigrenDaniel BengtssonPontus DunérKatarina OlofssonHarry BjörkbackaEva BengtssonGunilla Nordin FredriksonJan Nilsson. (2009) Atheroprotective Effects of Alum Are Associated With Capture of Oxidized LDL Antigens and Activation of Regulatory T Cells. Circulation Research 104:12.
Crossref
G. N. Fredrikson, H. Björkbacka, I. Söderberg, I. Ljungcrantz & J. Nilsson. (2008) Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies. Journal of Internal Medicine 264:6, pages 563-570.
Crossref
Elizabeth Riley, Vijaya Dasari, William H. Frishman & Kirk Sperber. (2008) Vaccines in Development to Prevent and Treat Atherosclerotic Disease. Cardiology in Review 16:6, pages 288-300.
Crossref
J. Nilsson & G. K. Hansson. (2008) Autoimmunity in atherosclerosis: a protective response losing control?. Journal of Internal Medicine 263:5, pages 464-478.
Crossref
P. Sjogren, G. N. Fredrikson, A. Samnegard, C.-G. Ericsson, J. Ohrvik, R. M. Fisher, J. Nilsson & A. Hamsten. (2008) High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction. European Heart Journal 29:18, pages 2218-2226.
Crossref
Per Sjögren, Gunilla N. Fredrikson, Magdalena Rosell, Ulf de Faire, Anders Hamsten, Jan Nilsson, Mai-Lis Hellenius & Rachel M. Fisher. (2008) Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men. Metabolism 57:3, pages 362-366.
Crossref
Natalia Milioti, Alexandra Bermudez-Fajardo, Manuel L. Penichet & Ernesto Oviedo-Orta. (2008) Antigen-Induced Immunomodulation in the Pathogenesis of Atherosclerosis. Clinical and Developmental Immunology 2008, pages 1-15.
Crossref
Johan Kuiper, Gijs HM van Puijvelde, Eva JA van Wanrooij, Thomas van Es, Kim Habets, Arnaud D Hauer & Theo JC van den Berkel. (2007) Immunomodulation of the inflammatory response in atherosclerosis. Current Opinion in Lipidology 18:5, pages 521-526.
Crossref
Gunilla Nordin Fredrikson, Alexandru Schiopu, Göran Berglund, Ragnar Alm, Prediman K. Shah & Jan Nilsson. (2007) Autoantibody against the amino acid sequence 661–680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events. Atherosclerosis 194:2, pages e188-e192.
Crossref
Gunilla Nordin FredriksonBo HedbladGöran BerglundRagnar AlmJan-Åke NilssonAlexandru SchiopuPrediman K. ShahJan Nilsson. (2007) Association Between IgM Against an Aldehyde-Modified Peptide in Apolipoprotein B-100 and Progression of Carotid Disease. Stroke 38:5, pages 1495-1500.
Crossref
Charles W. Rittershaus. (2007) Vaccines for Cholesterol Management. World Journal of Surgery 31:4, pages 690-694.
Crossref
Åsa Ström, Gunilla Nordin Fredrikson, Alexandru Schiopu, Irena Ljungcrantz, Ingrid Söderberg, Bo Jansson, Roland Carlsson, Anna Hultgårdh-Nilsson & Jan Nilsson. (2007) Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100. Atherosclerosis 190:2, pages 298-305.
Crossref
Einar E Eriksson. (2006) Atherosclerosis: cell biology and lipoproteins. Current Opinion in Lipidology 17:3, pages 369-371.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.